Rxsight Inc
RXST7.850USD
+0.050+0.64%
交易中 （美东）报价延迟15分钟
318.62M总市值
亏损市盈率 TTM
关于 Rxsight Inc 公司
RxSight, Inc. 是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。该公司的 RxSight 可调光晶状体系统 (RxSight 系统) 是一种白内障技术，可让医生在手术后为患者定制和优化视力。RxSight 系统包括 RxSight 可调光晶状体 (LAL)、RxSight 光传输装置 (LDD) 和各种配件。其 LAL 是一种由感光材料制成的人工晶状体 (IOL)，可根据其 LDD 产生的特定模式的紫外线 (UV) 光改变形状。该公司设计其 RxSight 系统是为了解决竞争性 IOL 技术的缺点，并提供医生可以信赖的解决方案来改善视觉效果。其 RxSight 系统可帮助外科医生执行标准的白内障手术以植入 LAL，然后使用 LDD 修改晶状体，以达到患者视力所需的视力矫正效果。
公司简介
公司代码RXST
公司名称Rxsight Inc
上市日期Jul 30, 2021
CEODr. Ron M. Kurtz, M.D.
员工数量498
证券类型Ordinary Share
年结日Jul 30
公司地址100 Columbia Street
城市ALISO VIEJO
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编92656
电话19495217822
网址https://www.rxsight.com/
公司代码RXST
上市日期Jul 30, 2021
CEODr. Ron M. Kurtz, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
收入明细
FY2024
暂无数据
地区USD
名称
营收
占比
United States
139.93M
0.00%
业务
地区
暂无数据
股东统计
更新时间: 6月2日 周一
更新时间: 6月2日 周一
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
持股股东
持股股东
占比
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
股东类型
持股股东
占比
Investment Advisor
39.90%
Investment Advisor/Hedge Fund
20.21%
Hedge Fund
19.12%
Venture Capital
9.26%
Research Firm
7.81%
Individual Investor
5.51%
Pension Fund
1.27%
Private Equity
0.57%
Bank and Trust
0.46%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
444
40.56M
99.81%
-3.90M
2025Q1
453
40.49M
99.79%
-7.96M
2024Q4
440
38.96M
96.23%
-5.07M
2024Q3
420
38.15M
94.75%
-3.92M
2024Q2
391
37.00M
93.42%
-2.64M
2024Q1
338
34.63M
93.15%
-2.60M
2023Q4
299
33.17M
91.51%
-284.01K
2023Q3
253
34.41M
96.36%
-1.84M
2023Q2
214
31.39M
90.12%
+2.22M
2023Q1
160
26.47M
84.63%
+4.14M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
3.74M
9.21%
--
--
Mar 31, 2025
Millennium Management LLC
897.85K
2.21%
-109.69K
-10.89%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
6.29%
-18.59K
-0.72%
Mar 31, 2025
Divisadero Street Capital Management, LP
2.53M
6.23%
+1.65M
+185.91%
Apr 03, 2025
The Vanguard Group, Inc.
2.38M
5.87%
+8.50K
+0.36%
Mar 31, 2025
BofA Global Research (US)
2.18M
5.37%
+35.62K
+1.66%
Mar 31, 2025
Artisan Partners Limited Partnership
1.77M
4.35%
+215.90K
+13.91%
Mar 31, 2025
Brown Capital Management, LLC
947.29K
2.33%
+105.10K
+12.48%
Mar 31, 2025
State Street Global Advisors (US)
898.67K
2.21%
+7.87K
+0.88%
Mar 31, 2025
Fidelity Management & Research Company LLC
888.74K
2.19%
-41.99K
-4.51%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPDR S&P Health Care Equipment ETF
1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
Nuveen ESG Small-Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
WisdomTree US SmallCap Fund
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Global X Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
查看更多
SPDR S&P Health Care Equipment ETF
占比1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
占比0.04%
Nuveen ESG Small-Cap ETF
占比0.04%
iShares Russell 2000 Growth ETF
占比0.03%
iShares Russell 2000 ETF
占比0.02%
WisdomTree US SmallCap Fund
占比0.02%
ProShares Hedge Replication ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
Global X Russell 2000 ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
